Drug Type Enzyme |
Synonyms AMFA engineered enzyme (NanoMedSyn) |
Target |
Mechanism M6PR inhibitors(Mannose-6-phosphate receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glycogen Storage Disease Type II | Preclinical | FR | 24 Sep 2024 |